Beth Darnall, PhD, and Sean Mackey, MD PhD, are quoted in the recent article “How to Break the Bonds of Opioids” about opioid tapering challenges and patient-centered solutions.
Learn more (subscription required).
Beth Darnall, PhD, and Sean Mackey, MD PhD, are quoted in the recent article “How to Break the Bonds of Opioids” about opioid tapering challenges and patient-centered solutions.
Learn more (subscription required).
The U.S. Department of Health and Human Services (HHS) published a new Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics. Individual patients, as well as the health of the public, benefit when opioids are prescribed only when the benefit of using opioids outweighs the risks. But once a patient is on opioids for a prolonged duration, any abrupt change in the patient’s regimen may put the patient at risk of harm and should include a thorough, deliberative case review and discussion with the patient. The HHS Guide provides advice to clinicians who are contemplating or initiating a change in opioid dosage.
Today, the U.S. Department of Health and Human Services published a new Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics – PDF. Individual patients, as well as the health of the public, benefit when opioids are prescribed only when the benefit of using opioids outweighs the risks. But once a patient is on opioids for a prolonged duration, any abrupt change in the patient’s regimen may put the patient at risk of harm and should include a thorough, deliberative case review and discussion with the patient. The HHS Guide provides advice to clinicians who are contemplating or initiating a change in opioid dosage.
AAPM member Beth Darnall, PhD, recently spoke at the annual meeting of the Patient-Centered Outcomes Research Institute about tapering opioids and the EMPOWER (Effective Management of Pain and Opioid-Free Ways to Enhance Relief) study her team is currently conducting.